Association of germline ABCB1 and ERCC1 polymorphisms with CDK4/6 inhibitor-induced neutropenia in patients with breast cancer: a systematic review and meta-analysis.

Dimulescu MD, Lungulescu CV, Riza AL, Streata I, Patrascu RA, Capraru AM, Naidin MS, Ungureanu BS, Gheonea IA, Turcu-Stiolica A

Open source

DOI
10.3389/fphar.2026.1872557
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1872557,
  title = {Association of germline ABCB1 and ERCC1 polymorphisms with CDK4/6 inhibitor-induced neutropenia in patients with breast cancer: a systematic review and meta-analysis.},
  author = {Dimulescu MD and Lungulescu CV and Riza AL and Streata I and Patrascu RA and Capraru AM and Naidin MS and Ungureanu BS and Gheonea IA and Turcu-Stiolica A},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1872557},
  url = {https://doi.org/10.3389/fphar.2026.1872557}
}

RIS

TY  - JOUR
TI  - Association of germline ABCB1 and ERCC1 polymorphisms with CDK4/6 inhibitor-induced neutropenia in patients with breast cancer: a systematic review and meta-analysis.
AU  - Dimulescu MD
AU  - Lungulescu CV
AU  - Riza AL
AU  - Streata I
AU  - Patrascu RA
AU  - Capraru AM
AU  - Naidin MS
AU  - Ungureanu BS
AU  - Gheonea IA
AU  - Turcu-Stiolica A
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1872557
UR  - https://doi.org/10.3389/fphar.2026.1872557
ER  - 

APA

MD, D., CV, L., AL, R., I, S., RA, P., AM, C., MS, N., BS, U., IA, G., & A, T. (2026). Association of germline ABCB1 and ERCC1 polymorphisms with CDK4/6 inhibitor-induced neutropenia in patients with breast cancer: a systematic review and meta-analysis.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1872557

Source records